Background Neuraminidase inhibitors (NIs) are stockpiled and recommended by public
health agencies for treating and preventing seasonal and pandemic influenza. They are …

Objectives To update a 2005 Cochrane review that assessed the effects of neuraminidase
inhibitors in preventing or ameliorating the symptoms of influenza, the transmission of …

Importance Antiviral treatment of influenza is recommended for patients with influenza-like
illness during periods of community cocirculation of influenza viruses and SARS-CoV-2; …

Background: The antiviral effect of anti-influenza drugs such as zanamivir may be
demonstrated in patients as an increased rate of decline in viral load over a time course of …

Background Use of antivirals is recommended for the control of seasonal and pandemic
influenza. Our aim was to review the evidence of efficacy, effectiveness, and safety of …

Unpublished and misreported studies make it difficult to determine the true value of a
treatment. Peter Doshi and colleagues call for sponsors and investigators of abandoned …

Background Neuraminidase inhibitors (NI) are recommended for use against influenza and
its complications in inter‐pandemic years and during pandemics. Objectives To assess the …

Background. DAS181, a novel host-directed antiviral in development for influenza treatment,
was assessed in this phase II clinical trial. Methods. This study was a double-blind, placebo …

Controversy has arisen regarding the effectiveness of neuraminidase inhibitors (NIs),
especially against influenza-related complications. A literature search was performed to …

Recent spread of avian influenza A (H5N1) virus to poultry and wild birds has increased the
threat of human infections with H5N1 virus worldwide. Despite international agreement to …